Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2018

Open Access 01-12-2018 | Research article

Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus

Authors: S. P. Vibha, Muralidhar M. Kulkarni, A. B. Kirthinath Ballala, Asha Kamath, G. Arun Maiya

Published in: BMC Endocrine Disorders | Issue 1/2018

Login to get access

Abstract

Background

Diabetic foot is one of the most significant and devastating complication of diabetes. The objective of this study was to assess the prevalence of diabetic foot syndrome (DFS) and the associated risk factors among people with diabetes mellitus.

Methods

A community based cross-sectional study was carried out among 620 subjects with diabetes mellitus (DM) in rural areas of Udupi district. The Michigan Neuropathy Screening Instrument was used to identify peripheral neuropathy. Ankle brachial index was used to identify peripheral arterial disease (PAD). Subjects with diabetic foot syndrome were classified according to the International Working Group on Diabetic Foot (IWGDF) classification system.

Results

The overall prevalence of DFS was 51.8%. Among them 31.3, 11.9 and 8.5% belonged to category 1, 2 and 3 respectively. Multivariate logistic regression analysis showed advancing age, low socio-economic status, sedentary physical activity and longer duration of DM were significant independent correlates of DFS.

Conclusion

The overall prevalence of DFS was high among the study population; hence the screening for foot complications should start at the time of diagnosis of diabetes integrated with sustainable patient education at primary care level by training of health care providers at primary care level.
Literature
1.
2.
3.
4.
Forlee M. What is the diabetic foot? The rising prevalence of diabetes worldwide will mean an increasing prevalence of complications such as those of the extremities. Continuing Medical Education. 2010;28:152–6.
5.
Jain AKC, Vishwanath S. Studying major amputations in a developing country using Amit Jain’s typing and scoring system for diabetic foot complications - time for standardization of diabetic foot practice. Int Surg J. 2015;2:26–30.CrossRef
6.
7.
Katsilambros N, Dounis E, Makrilakis K, Tentolouris N, Tsapogas P. Atlas of the diabetic foot. John Wiley & Sons. 2010.CrossRef
8.
Bakkar K, Foster A, Houtum WV, Riley P. Diabetes and Foot Care: Time to act. 4th edition. Netherlands: 2005.
9.
George H, Rakesh PS, Krishna M, Alex R, Abraham VJ, George K, Prasad JH. Foot care knowledge and practices and the prevalence of peripheral neuropathy among people with diabetes attending a secondary care rural hospital in southern India. J Fam Med Primary Care. 2013;2:27–32.CrossRef
10.
Ramachandran A, Snehalatha C, Baskar ADS, Mary S, Sathish Kumar CK, Selvam S, Catherine S, Vijay V. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia. 2004;47:860–5.CrossRefPubMed
11.
Kulkarni MM, Shetty RS, Kamath A, Kamath VG, Varun N, Ramprasad VP. Tobacco use among adults in a rural area of coastal Karnataka. Indian Journal of Preventative Medicine. 2015;3:63–6.CrossRef
12.
World Health Organization. Waist circumference and waist-hip ratio. Geneva: Report of a WHO expert consultation; 2008.
13.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–71.CrossRefPubMed
14.
15.
Bus SA, Netten JJ, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, Price PE. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab Res Rev. 2016;32:16–24.CrossRefPubMed
16.
Potier L, Khalil CA, Mohammedi KA, Roussel R. Use and Utility of ankle brachial index in patients with diabetic. Eur J Vasc Endovasc Surg. 2011;41:110–6.CrossRefPubMed
17.
Kishore S, Upadhyay AD, Jyotsna VP. Categories of foot at risk in patients of diabetes at a tertiary care center: insights into need for foot care. Indian J Endocrinol Metab. 2015;19:405–9.CrossRefPubMedPubMedCentral
18.
Lavary LA, Armstrong DG, Wunderlich RP, Terdwell J, Boulton A. Evaluation the prevalence and incidence of foot pathology in Mexican-Americans and Nonhispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;23:1435–8.CrossRef
19.
Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the international working group on the diabetic foot. Diabetes Care. 2001;24:1442–7.CrossRefPubMed
20.
Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–9.CrossRefPubMed
21.
Moghtaderi A, Bakhshipour A, Rashidi H. (2006). Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg. 2006;108:477–1.CrossRefPubMed
22.
Nongmaithem M, Bawa APS, Pithwa AK, Bhatia SK, Singh G, Gooptu S. A study of risk factors and foot care behavior among diabetics. J Family Med Prim Care. 2016;5:399.CrossRefPubMedPubMedCentral
23.
Pop-Busui R, Lu J, Lopes N, Jones TL. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst. 2009;14:1–3.CrossRefPubMedPubMedCentral
24.
Jember G, Melsew YA, Fisseha B, Sany K, Gelaw AY, Janakiraman B. Peripheral sensory neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia. J Diabetes Metab Disord. 2017;16:16–20.CrossRefPubMedPubMedCentral
25.
Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5:714–21.CrossRefPubMedPubMedCentral
26.
Gous SS, Suhail M, Hussain SAA, Shafee M. Prevalence of diabetic peripheral neuropathy and associated risk factors in type 2 diabetes patients attending a diabetes care Centre in Maharashtra. International journal of recent trends in. Sci Technol. 2015;16:620–3.
27.
D’Souza M, Kulkarni V, Bhaskaran U, Ahmed H, Naimish H, Prakash A. Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care Centre in Mangalore, India. J Public Health Res. 2015;4:120–4.CrossRef
28.
Nagaraj C, Ramakuri M, Konapur KS. Burden of foot problems in diabetic subjects-a community-based study among urban poor in Bangalore. India Education. 2014;48:73–85.
29.
30.
Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian J Med Sci. 2010;64:51–7.CrossRefPubMed
31.
Shahi SK, Kumar A, Kumar S, Singh SK. Prevalence of diabetic foot ulcer and associated risk factors in diabetic patients from North India. Age. 2012;47:55–6.
32.
Viswanathan V, Madhavan S, Rajasekar S, Chamukuttan S, Ambady R. Urban-rural differences in the prevalence of foot complications in south-Indian diabetic patients. Diabetes Care. 2006;29:701–3.CrossRefPubMed
33.
Zubair M, Malik A, Ahmad J. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a north Indian tertiary care hospital. Foot. 2012;22:24–30.CrossRef
34.
Jaiswal M, Lauer A, Martin CL, Bell RA, Divers J, Dabelea D, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Rodriguez BL. Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for diabetes in youth follow-up cohort. Diabetes Care. 2013;36:3903–8.CrossRefPubMedPubMedCentral
35.
Al-Kaabi JM, Al Maskari F, Zoubeidi T, Abdulle A, Shah SM. Prevalence and determinants of peripheral neuropathy in patients with type 2 diabetes attending a tertiary care center in the United Arab Emirates. J Diabetes Metab Disord. 2014;5:2–9.
36.
Agrawal R, Ola V, Bishnoi P, Gothwal S, Sirohi P, Agrawal R. Prevalence of micro and macrovascular complications and their risk factors in type-2 diabetes mellitus. J Assoc Physicians India. 2014;62:504–8.PubMed
37.
Alex R, Ratnaraj B, Winston B, Devakiruba DN, Samuel C, John J, Mohan VR, Prasad JH, Jacob KS. (2010). Risk factors for foot ulcers in patients with diabetes mellitus-a short report from Vellore, South India. Indian J Community Med. 2010;35:183–5.CrossRefPubMedPubMedCentral
Metadata
Title
Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus
Authors
S. P. Vibha
Muralidhar M. Kulkarni
A. B. Kirthinath Ballala
Asha Kamath
G. Arun Maiya
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2018
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-018-0270-2

Other articles of this Issue 1/2018

BMC Endocrine Disorders 1/2018 Go to the issue

Research article

Quality improvement strategies at primary care level to reduce inequalities in diabetes care: an equity-oriented systematic review

Research article

Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?

Research article

Clinical Management of Malignant Insulinoma: a single Institution’s experience over three decades

Case report

Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman – a case report

Research article

Barriers and facilitators to taking on diabetes self-management tasks in pre-adolescent children with type 1 diabetes: a qualitative study

Case report

Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits